Annika Jögi
Annika Jögi
Associate professor of Molecular medicine, Lund University, Sweden
Verifierad e-postadress på med.lu.se
TitelCiteras avÅr
Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype
A Jögi, I Øra, H Nilsson, Å Lindeheim, Y Makino, L Poellinger, H Axelson, ...
Proceedings of the National Academy of Sciences 99 (10), 7021-7026, 2002
3842002
Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ
K Helczynska, Å Kronblad, A Jögi, E Nilsson, S Beckman, G Landberg, ...
Cancer research 63 (7), 1441-1444, 2003
2242003
Induction of ID2 expression by hypoxia-inducible factor-1 a role in dedifferentiation of hypoxic neuroblastoma cells
T Löfstedt, A Jögi, M Sigvardsson, K Gradin, L Poellinger, S Påhlman, ...
Journal of Biological Chemistry 279 (38), 39223-39231, 2004
1522004
Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior
A Jögi, J Vallon-Christersson, L Holmquist, H Axelson, Å Borg, S Påhlman
Experimental cell research 295 (2), 469-487, 2004
1222004
Modulation of basic helix-loop-helix transcription complex formation by Id proteins during neuronal differentiation
A Jögi, P Persson, A Grynfeld, S Påhlman, H Axelson
Journal of Biological Chemistry 277 (11), 9118-9126, 2002
1202002
Cancer cell differentiation heterogeneity and aggressive behavior in solid tumors
A Jögi, M Vaapil, M Johansson, S Påhlman
Upsala journal of medical sciences 117 (2), 217-224, 2012
762012
HIF-2α expression in human fetal paraganglia and neuroblastoma: relation to sympathetic differentiation, glucose deficiency, and hypoxia
H Nilsson, A Jögi, S Beckman, AL Harris, L Poellinger, S Påhlman
Experimental cell research 303 (2), 447-456, 2005
752005
Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer
A Jögi, DJ Brennan, L Rydén, K Magnusson, M Fernö, O Stål, S Borgquist, ...
Modern Pathology 22 (12), 1564, 2009
692009
HASH-1 and E2-2 are expressed in human neuroblastoma cells and form a functional complex
P Persson, A Jögi, A Grynfeld, S Påhlman, H Axelson
Biochemical and biophysical research communications 274 (1), 22-31, 2000
652000
Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer
S Borgquist, A Jögi, F Pontén, L Rydén, DJ Brennan, K Jirström
Breast cancer research 10 (5), R79, 2008
492008
Hypoxia-induced dedifferentiation in neuroblastoma cells
A Jögi, I Øra, H Nilsson, L Poellinger, H Axelson, S Påhlman
Cancer letters 197 (1-2), 145-150, 2003
482003
Phenotypic persistence after reoxygenation of hypoxic neuroblastoma cells
L Holmquist, A Jögi, S Påhlman
International journal of cancer 116 (2), 218-225, 2005
452005
Antibody-mediated targeting of the urokinase-type plasminogen activator proteolytic function neutralizes fibrinolysis in vivo
IK Lund, A Jögi, B Rønø, MG Rasch, LR Lund, K Almholt, H Gårdsvoll, ...
Journal of Biological Chemistry 283 (47), 32506-32515, 2008
292008
Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptormediated uPA activity in vitro and in vivo
J Pass, A Jögi, IK Lund, B Rønø, MG Rasch, H Gårdsvoll, LR Lund, ...
Thrombosis and haemostasis 97 (06), 1013-1022, 2007
282007
Hypoxic conditions induce a cancer-like phenotype in human breast epithelial cells
M Vaapil, K Helczynska, R Villadsen, OW Petersen, E Johansson, ...
PloS one 7 (9), e46543, 2012
262012
Neutralisation of uPA with a monoclonal antibody reduces plasmin formation and delays skin wound healing in tPA-deficient mice
A Jögi, B Rønø, IK Lund, BS Nielsen, M Ploug, G Høyer-Hansen, J Rømer, ...
PloS one 5 (9), e12746, 2010
202010
Systemic administration of anti‐urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue‐type plasminogen activator deficient mice
A Jögi, J Pass, G HØYER‐HANSEN, LR Lund, BS Nielsen, K Danø, ...
Journal of Thrombosis and Haemostasis 5 (9), 1936-1944, 2007
202007
EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation
S Reinbothe, AM Larsson, M Vaapil, C Wigerup, J Sun, A Jögi, ...
Biochemical and biophysical research communications 445 (1), 163-169, 2014
172014
HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells
MW Alam, CU Persson, S Reinbothe, JU Kazi, L Rönnstrand, C Wigerup, ...
Oncotarget 7 (10), 11238, 2016
142016
Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1
LI Påhlman, A Jögi, M Gram, M Mori, A Egesten
BMC pulmonary medicine 15 (1), 19, 2015
112015
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20